Form 8-K - Current report:
SEC Accession No. 0000950170-25-041749
Filing Date
2025-03-19
Accepted
2025-03-19 08:06:08
Documents
13
Period of Report
2025-03-19
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K onvo-20250319.htm   iXBRL 8-K 45710
2 EX-99.1 onvo-ex99_1.htm EX-99.1 16224
3 GRAPHIC img73928077_0.jpg GRAPHIC 7360
  Complete submission text file 0000950170-25-041749.txt   189404

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT onvo-20250319.xsd EX-101.SCH 24862
15 EXTRACTED XBRL INSTANCE DOCUMENT onvo-20250319_htm.xml XML 4706
Mailing Address 11555 SORRENTO VALLEY ROAD SUITE 100 SAN DIEGO CA 92121
Business Address 11555 SORRENTO VALLEY ROAD SUITE 100 SAN DIEGO CA 92121 858-224-1000
ORGANOVO HOLDINGS, INC. (Filer) CIK: 0001497253 (see all company filings)

EIN.: 271488943 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-35996 | Film No.: 25750899
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)